Nine Square Therapeutics Appoints Robert Paul as CEO

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Jan. 11, 2022 /PRNewswire/ -- Nine Square Therapeutics, a biotechnology company applying computational chemistry and machine-learning enabled cell profiling to discover and develop novel small-molecule therapeutics for movement disorders including Parkinson's and ALS, announced today that Robert Paul, M.D., Ph.D., has joined...

Click to view original post